Wainua™ (eplontersen) – New orphan drug approval
December 21, 2023 - AstraZeneca and Ionis announced the FDA approval of Wainua (eplontersen), for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Download PDF
